BioPharm News

Dec 01, 2017
By BioPharm International Editors
The company has opened a new California facility that, combined with its existing site in Foster City, CA, will quadruple its laboratory footprint for gene therapy products.
Dec 01, 2017
By BioPharm International Editors
Lonza has entered into strategic license agreements for exclusive rights to a gene-therapy platform for developing treatments for hearing and balance disorders.
Nov 30, 2017
Experts slam drug prices and endorse government price negotiations and curbs on drug advertising.
Nov 29, 2017
By BioPharm International Editors
Binding Site has introduced a number of new monoclonal antibodies targeting infectious diseases, including cytomegalovirus, hepatitis (A, B, C, and D), herpes, human immunodeficiency virus (HIV), rubella, and toxoplasma.
Nov 29, 2017
By BioPharm International Editors
Biocad and Sothema Labs have partnered to release cancer-treating biosimilars into the North African market.
Nov 28, 2017
By BioPharm International Editors
The joint venture will focus on the discovery, development, and commercialization of potential new drugs for the global market as well as speed delivery of new medicines to China.
Nov 28, 2017
By BioPharm International Editors
The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.
Nov 27, 2017
By BioPharm International Editors
The new guidelines discuss GMPs and patient protection specific to advanced therapy medicinal products.
Nov 27, 2017
Manufacturers and trading partners struggle to meet drug tracking requirements
Nov 21, 2017
By BioPharm International Editors
Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected to start up in March 2019.
native1_300x100
lorem ipsum